CentoRx: Started Phase III trial

Centocor Inc. (CNTO) Product: CentoRx antibody fragment GPIIb/IIIa inhibitor Indication: Refractory unstable angina patients scheduled for angioplasty Status: Started Phase III trial in Europe ...